Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease

Clinical trial NCT06526299 · RECRUITING

Trial details

NCT number: NCT06526299
Sponsor: University of Washington
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Castration-Resistant Prostate Carcinoma Stage IVB Prostate Cancer AJCC v8

Start date: 2025-04-29
Primary completion: 2027-12-31
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.